(no title)
sammalloy | 2 years ago
This all came together as something called the entheogenic hypothesis. It is often used to explain the connection between the evolution of religion and the purported sacraments that may have been used in formal rites. The Eleusinian Mysteries is often referenced as an example. Campbell’s formulation of the "Hero’s journey" is very often seen as a general archetype for the user of these substances in its synthesis of comparative literature (which features these forms as archetypes) and mythology which also translates to religion itself. In Campbell’s formulation, the "boon" that is brought back from the hero, is overlayed and represented in the entheogenic hypothesis as the very informational content that the psychonaut is able to retrieve from the experiences. McKenna often interpreted this as the "logos" but in a more secular context. Lilly and others heard distinct voices giving them instructions. Shanon and others revisited the Abrahamic stories and posited that these voices giving people instructions were equivalent to what ancient people imagined as the voice of god. Still others, like Julian Jaynes, interpreted this idea in a secular way, seeing it more as a story that explains our transition from partial to full consciousness. More recently, the writers of Westworld took a lot of these ideas and applied them to AI, in an attempt to explain how consciousness could eventually emerge again as AGI.
n4r9|2 years ago
Is there really no way? I can imagine for example conducting a double-blind trial with various psychedelics and controls, and recording the subjects' verbalised experiences during and after the trip. This would give some strong clues as to which aspects of the experience are inherent/neurochemical, and which are culutrally primed.
You can go even further and test it with people that have never heard of psychedelic drugs, let alone been culturally primed. It would take a lot of funding of course, but in principle it's possible.
I totally accept that we know very little about the brain to have a good mechanistic understanding of subjective experience. But I think we're making great progress! A few years ago I went to a lecture by David Nutt, who researches the potential for psilocybin and ketamine therapies to treat depression. What struck me was that it is already possible to measure and talk scientifically about the mechanistic effects of psychedelic drugs on the brain, and how those measured effects correlate to lived experience.